Financials CohBar, Inc.

Equities

CWBR

US19249J3077

Biotechnology & Medical Research

Market Closed - OTC Markets 01:57:53 2024-06-13 pm EDT 5-day change 1st Jan Change
0.78 USD 0.00% Intraday chart for CohBar, Inc. -3.74% +5.41%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 195.9 132.4 68.6 81.9 30.11 4.927
Enterprise Value (EV) 1 187.5 113.1 59.39 61.58 4.231 -10.81
P/E ratio -18.9 x -8.17 x -5.25 x -4.02 x -1.51 x -0.4 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -19.1 x -7.41 x -4.78 x -4.72 x -0.28 x 0.88 x
EV / FCF -54 x -23.5 x -10.8 x -11.7 x -0.49 x 1.79 x
FCF Yield -1.85% -4.25% -9.28% -8.57% -205% 55.9%
Price to Book 25.7 x 7.37 x 8.47 x 4.43 x 1.18 x 0.32 x
Nbr of stocks (in thousands) 1,314 1,419 1,429 2,037 2,869 2,907
Reference price 2 149.1 93.30 48.00 40.20 10.50 1.695
Announcement Date 4/2/18 3/18/19 3/12/20 3/30/21 3/29/22 3/9/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA 1 -9.802 -15.26 -12.44 -13.04 -15.27 -12.29
EBIT 1 -9.859 -15.33 -12.58 -13.2 -15.41 -12.39
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -9.833 -15.71 -13.04 -16.26 -15.48 -12.18
Net income 1 -9.833 -15.71 -13.04 -16.26 -15.48 -12.18
Net margin - - - - - -
EPS 2 -7.871 -11.42 -9.140 -9.996 -6.968 -4.200
Free Cash Flow 1 -3.47 -4.809 -5.511 -5.277 -8.654 -6.046
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/2/18 3/18/19 3/12/20 3/30/21 3/29/22 3/9/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales 1 - - - - - - -
EBITDA - - - - - - -
EBIT 1 -4.013 -5.202 -3.411 -2.482 -3.251 -2.744 -2.471
Operating Margin - - - - - - -
Earnings before Tax (EBT) -4.038 -5.223 -3.422 -2.792 -3.262 -2.725 -
Net income -4.038 -5.223 -3.422 -2.792 -3.262 -2.725 -
Net margin - - - - - - -
EPS -2.100 -2.400 -1.500 -0.9000 -1.200 -0.9000 -
Dividend per Share - - - - - - -
Announcement Date 5/17/21 8/10/21 11/15/21 3/29/22 5/16/22 8/15/22 11/8/22
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 8.45 19.3 9.21 20.3 25.9 15.7
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -3.47 -4.81 -5.51 -5.28 -8.65 -6.05
ROE (net income / shareholders' equity) -121% -123% -100% -122% -70.2% -59.5%
ROA (Net income/ Total Assets) -66.8% -60.1% -43% -46.6% -39.1% -35.5%
Assets 1 14.72 26.14 30.33 34.94 39.54 34.33
Book Value Per Share 2 5.800 12.70 5.670 9.070 8.900 5.270
Cash Flow per Share 2 2.150 4.030 8.750 1.420 1.730 2.040
Capex 1 0 0.42 0.15 0.03 0.01 -
Capex / Sales - - - - - -
Announcement Date 4/2/18 3/18/19 3/12/20 3/30/21 3/29/22 3/9/23
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. CWBR Stock
  4. Financials CohBar, Inc.